Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

NDA submitted for brentuximab vedotin in Japan

March 25, 2013

Prima BioMed earns grant to support development of CVac

March 22, 2013

MHC class I-restricted vaccines prove clinically active against metastatic RCC

March 22, 2013

Supplemental BLA submitted to expand Adcetris use in U.S.

March 19, 2013

A novel glycooptimized biobetter of cetuximab is well tolerated in first-in-human trials

March 18, 2013

Novel cancer peptide vaccines prepared in Japan

March 15, 2013

Activartis gives update on its anticancer immune therapy for glioma

March 14, 2013

Patrys reports additional data from phase I/IIa PAT-SM6 study

March 11, 2013

OncoMed begins dosing in phase I trial of anti-Notch 1 antibody in solid tumors

March 11, 2013

Roche obtains E.U. approval for Perjeta

March 6, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...